 ICPT | Intercept Pharma Company profile
About the CompanyIntercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.
Address10 Hudson Yards Key Persons / Board of Directors
Videos about Intercept Pharma | NotesJump to (Finance sites)          ResearchInvestor pageir.interceptpharma.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: interceptpharma.com
Their Official Profiles   Peers / Similar stocks    Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities. A simple, straightforward guide to the fundamentals of technical analysis |
